Y Eriguchi1, K Nakamura2, D Hashimoto3, S Shimoda1, N Shimono1, K Akashi1, T Ayabe2, T Teshima3. 1. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan. 2. Department of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan. 3. Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Abstract
BACKGROUND: Intestinal microbial ecology is actively regulated by Paneth cell-derived antimicrobial peptides, α-defensins. Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (SCT). We previously demonstrated that Paneth cells are targeted by GVHD, and their expression of antimicrobial peptide α-defensins is impaired, leading to a loss of physiological diversity among the microflora and development of bloodstream infection. Herein, we evaluated whether fecal levels of α-defensins could be surrogate marker of intestinal dysbiosis. METHODS: We directly measured α-defensin cryptdin-1 (Crp1) in fecal pellets of mice with GVHD by using a novel enzyme-linked immunosorbent assay. RESULTS: Fecal levels of Crp1 were significantly decreased in mice with GVHD but unchanged in mice without GVHD after SCT. These were correlated with intestinal flora diversity. CONCLUSION: We demonstrate a link between reduced secretion of Paneth cell α-defensins and dysbiosis of intestinal flora in GVHD. Fecal levels of α-defensins could be surrogate markers for intestinal microbial homeostasis.
BACKGROUND: Intestinal microbial ecology is actively regulated by Paneth cell-derived antimicrobial peptides, α-defensins. Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (SCT). We previously demonstrated that Paneth cells are targeted by GVHD, and their expression of antimicrobial peptide α-defensins is impaired, leading to a loss of physiological diversity among the microflora and development of bloodstream infection. Herein, we evaluated whether fecal levels of α-defensins could be surrogate marker of intestinal dysbiosis. METHODS: We directly measured α-defensin cryptdin-1 (Crp1) in fecal pellets of mice with GVHD by using a novel enzyme-linked immunosorbent assay. RESULTS: Fecal levels of Crp1 were significantly decreased in mice with GVHD but unchanged in mice without GVHD after SCT. These were correlated with intestinal flora diversity. CONCLUSION: We demonstrate a link between reduced secretion of Paneth cell α-defensins and dysbiosis of intestinal flora in GVHD. Fecal levels of α-defensins could be surrogate markers for intestinal microbial homeostasis.
Authors: Eduardo R Cobo; Ravi Holani; France Moreau; Kiminori Nakamura; Tokiyoshi Ayabe; Jennifer R Mastroianni; Yoshihiro Eriguchi; Andre Ouellette; Kris Chadee Journal: Infect Immun Date: 2018-06-21 Impact factor: 3.441
Authors: Daniela Weber; Robert R Jenq; Jonathan U Peled; Ying Taur; Andreas Hiergeist; Josef Koestler; Katja Dettmer; Markus Weber; Daniel Wolff; Joachim Hahn; Eric G Pamer; Wolfgang Herr; André Gessner; Peter J Oefner; Marcel R M van den Brink; Ernst Holler Journal: Biol Blood Marrow Transplant Date: 2017-02-14 Impact factor: 5.742
Authors: Armin Rashidi; Ryan Shanley; Sophia L Yohe; Bharat Thyagarajan; Julie Curtsinger; Claudio Anasetti; Edmund K Waller; Bart L Scott; Bruce R Blazar; Daniel J Weisdorf Journal: Br J Haematol Date: 2018-07-13 Impact factor: 6.998
Authors: Armin Rashidi; Adam Herman; Antonio L C Gomes; Jonathan U Peled; Robert R Jenq; Daniel G Brereton; Christopher Staley; Bruce R Blazar; Daniel J Weisdorf Journal: Br J Haematol Date: 2020-02-21 Impact factor: 6.998
Authors: Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt Journal: Biol Blood Marrow Transplant Date: 2018-02-19 Impact factor: 5.742